Evidence map›Paper›PMID 25749206›Full record

ArticleDiabetes technology & therapeutics2015

Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.

Gabriela H Telo, Lisa K Volkening, Deborah A Butler, Lori M Laffel

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Diabetes technology & therapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01472159 nacompletednot on this map

Optimizing CGM Use and Metabolic Outcomes in Youth With Type 1 Diabetes

TypeinterventionalSponsorJoslin Diabetes CenterRan2011 to 2015Enrolled130ConditionsType 1 DiabetesArmsCGM Family Teamwork Intervention
NCT02530450 completednot on this map

iPro Continuous Glucose Monitor in Children With Poorly Controlled Diabetes: A 6-Month, Randomized, Interventional Pilot Study

TypeobservationalSponsorThe University of Texas Health Science Center at San AntonioRan2011 to 2013Enrolled30ConditionsType 1 Diabetes MellitusArmscontinuous glucose monitoring (CGM)
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Recruitment Into a Pediatric Continuous Glucose Monitoring RCT.Journal of diabetes science and technology · 2017
    Trial
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Decisions in the Psychology of Glucose Monitoring.Journal of diabetes science and technology · 2019
    Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 3 countries.

Gabriela H Telo1 Pediatric, Adolescent, & Young Adult and Genetics and Epidemiology Sections, Joslin Diabetes Center, Harvard Medical School , Boston, Massachusetts.
Lisa K Volkening
Deborah A Butler
Lori M Laffel
Joslin Diabetes Center · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Optimizing CGM Use and Metabolic Outcomes in Youth with Type 1 DiabetesR01DK089349 · NIDDK · JOSLIN DIABETES CENTER · PI LAFFEL, LORI M · 2010 to 2013
$2.8M
NIDDK NIH HHS P30DK036836NIDDK NIH HHS R01 DK089349NIDDK NIH HHS R01DK089349
6 · The paper itself

Abstract

objectiveConsistent continuous glucose monitoring (CGM) use is a challenge in youth with type 1 diabetes. This study aimed to investigate patient and family behavioral and clinical characteristics associated with interest in implementing CGM. RESEARCH DESIGN AND

methodsIn a cross-sectional study, we compared 120 youth interested in starting CGM (the CGM group) with a general sample of 238 youth with type 1 diabetes (the Standard group). Youth and their parents completed validated surveys assessing adherence to diabetes management, diabetes-specific family conflict, parent involvement in diabetes management, and youth quality of life. Demographic and clinical data were obtained from chart review and interview.

resultsYouth participants had a mean age of 13.0±2.8 years, diabetes duration of 6.3±3.4 years, and hemoglobin A1c (HbA1c) level of 8.2±1.0% (66±11 mmol/mol). Youth in the CGM group performed more frequent blood glucose monitoring, had lower HbA1c levels, and were more likely to be treated by continuous subcutaneous insulin infusion (CSII) and to be living in two-parent homes than youth in the Standard group. Compared with the Standard group, youth interested in wearing a CGM device and their parents reported greater adherence to diabetes management, less diabetes-specific family conflict, and higher youth quality of life. No differences were found between groups with respect to parent involvement in diabetes management by both youth and parent reports.

conclusionsIn efforts to enhance CGM uptake, it is important to address factors such as blood glucose monitoring frequency, CSII use, adherence, and diabetes-specific family conflict when considering youth with type 1 diabetes for CGM implementation.

Indexed as

Patient Acceptance of Health CareAdolescentBlood GlucoseBlood Glucose Self-MonitoringChildCross-Sectional StudiesDiabetes Mellitus, Type 1Family ConflictFemaleGlycated HemoglobinHumansHypoglycemic AgentsInfusion Pumps, ImplantableInsulinInsulin Infusion SystemsMaleBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulin

Identifiers

PMID25749206
PMCPMC4432486
OpenAlexW2332994573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.